- Parenteral nutrition, which provides essential nutrients intravenously to patients unable to consume food orally or enterally, is becoming an increasingly critical component in Morocco’s healthcare landscape, particularly in intensive care units, oncology, and neonatal care settings due to its role in maintaining nutritional balance during severe illnesses
- The growing demand for parenteral nutrition in Morocco is primarily fueled by rising rates of chronic diseases, malnutrition, and post-surgical complications, alongside increased awareness among healthcare professionals about the benefits of clinical nutrition therapies
- Public and private hospitals in Morocco are leading the parenteral nutrition market with the largest revenue share in 2024, supported by government investments in healthcare infrastructure, enhanced diagnostic capabilities, and improved access to specialized treatment for vulnerable populations, including infants and the elderly
- The private healthcare sector is expected to be the fastest growing segment in the Morocco parenteral nutrition market during the forecast period due to growing medical tourism, urbanization, and rising demand for advanced patient care
- The single dose amino acid solution segment dominated the Morocco parenteral nutrition market with a market share of 40.5% in 2024, driven by its critical role in protein synthesis, tissue repair, and recovery in severely ill or malnourished patients
